The value of plants used in traditional medicine for drug discovery

Environmental Health Perspectives

Volumn 109, Issue SUPPL. 1, 2001, Pages 69-75

  Fabricant, D S ^a   Farnsworth, N R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Drug discovery; Ethnomedicine; Plants; Traditional medicine

Indexed keywords

ACETYLDIGOXIN; ADONIS VERNALIS EXTRACT; ADRISIA JAPONICA EXTRACT; AESCULUS HIPPOCASTANUM EXTRACT; AGRIMONIA EUPATORIA EXTRACT; AGRIMOPHOL; AJMALICINE; ALLYL ISOTHIOCYANATE; ANANAS COMOSUS EXTRACT; ARECA CATECHU EXTRACT; ARECOLINE; BELLADONNA ALKALOID; BERBERINE; BERBERIS VULGARIS EXTRACT; BERGENIN; BRASSICA NIGRA EXTRACT; BROMELAIN; CAFFEINE; CAMELLIA SINENSIS EXTRACT; CARICA PAPAYA EXTRACT; CATECHIN; CHYMOPAPAIN; DIGITALIS EXTRACT; ESCIN; ESCULETIN; FRAXINUS RHYNCHOPHYLLA EXTRACT; HERBACEOUS AGENT; PAPAVERINE; POTENTILLA FRAGAROIDES EXTRACT; RAUVOLFIA SERPENTINA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADONIS VERNALIS; ADRISIA JAPONICA; AESCULUS HIPPOCASTANUM; AGRIMONIA EUPATORIA; ANANAS COMOSUS; ANISODUS TANGUTICUS; ARECHA CATECHU; ARTICLE; BERBERIS VULGARIS; BRASSICA NIGRA; DIGITALIS LANATA; DRUG ACTIVITY; DRUG DEVELOPMENT; DRUG RESEARCH; DRUG STRUCTURE; DRUG USE; FRAXINUS RHYNCHOPHYLLA; MEDICAL RESEARCH; NONHUMAN; PAPAYA; PHYTOCHEMISTRY; PLANT; POTENTILLA FRAGAROIDES; PRIORITY JOURNAL; RAUVOLFIA SERPENTINA; SCREENING; SPECIES; TEA; TRADITIONAL MEDICINE;

ADONIS VERNALIS; AESCULUS HIPPOCASTANUM; AGRIMONIA EUPATORIA; ANANAS COMOSUS; ANISODUS TANGUTICUS; ARECA CATECHU; ATROPA BELLADONNA; BERBERIS VULGARIS; BRASSICA NIGRA; CAMELLIA SINENSIS; CARICA PAPAYA; DIGITALIS; DIGITALIS LANATA; EMBRYOPHYTA; FRAXINUS; FRAXINUS RHYNCHOPHYLLA; HIPPOCASTANUM; JAPONICA; LANATA; POTENTILLA; RAUVOLFIA SERPENTINA;

EID: 0035044430     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.01109s169     Document Type: Article

References (98)

1. A Neanderthal flower burial in northern Iraq
2. Medicinal plants in therapy
3. The future of plants as sources of new biodynamic compounds
4. Pharmacognosy in the new millennium: Leadfinding and biotechnology
5. Are prescription drug prices high?
6. The role of ethnopharmacology in drug development
7. Ethnopharmacology and drug development
8. Ethnopharmacology and Western medicine
9. The discovery of drugs from higher plants
10. Can ethnopharmacology contribute to the development of antiviral drugs?
11. Biological and phytochemical screening of plants
12. Problems and prospects of discovering new drugs from higher plants by pharmacological screening
13. Strategies for discovering drugs from previously unexplored natural products
14. Screening plants for new medicines
15. Biological and phytochemical evaluation of plants. I: Biological test procedures and results from 200 accessions
16. The role of medicinal plants in drug development
17. Plant folklore: A tool for predicting sources of antitumor activity?
18. Current status of the NCI plant and animal product program
19. Natural product source material use in the pharmaceutical industry: The Glaxo experience
20. The influence of natural products upon drug discovery
21. Natural products as a resource for new drugs
22. Biological and phytochemical evaluation of plants. III: False-negative saponin test results induced by the presence of tannins
23. Studies on false-positive alkaloid reactions with Dragendorff's reagent
24. Studies on alkaloid detecting reagents. II: Stability and sensitivity of modified Dragendorff's reagents
25. Natural products in drug discovery and development
26. Ethnobotany and drug discovery: The experience of the US National Cancer Institute
27. The National Cancer Institute's Natural Products Antineoplastic Development Program
28. New natural products under development at the National Cancer Institute. Recent results
29. Screening of Indian plants for biological activity. II
30. Screening of Indian plants for biological activity. III
31. Screening of Indian plants for biological activity. I
32. Screening of Indian plants for biological activity. IV
33. Screening of Indian plants for biological activity, V
34. Screening of Indian plants for biological activity. VI
35. Screening of Indian plants for biological activity. IX
36. Camptothecin and taxol: From discovery to clinic
37. Calanolide looks promising
38. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum
39. Research on medicinal plants at the Central Drug Research Institute, Lucknow
40. Folk-medicinal claims of western Uttar Pradesh, India
41. Folk use of medicinal herbs of Margalla Hills National Park, Islamabad
42. Ethnobotany of Caicaras of the Atlantic Forest Coast
43. Medicinal plants and food medicines in the folk traditions of the upper Lucca Province, Italy
44. Malay ethno-medico botany in Machang, Kelantan, Malysia
45. Medicinal plants used for peptic ulcer in the Bangangte region, western Cameroon
46. An Ethnobotanical Study in Central Anatolia
47. Folk medicinal plants of riverside forests of the Southern Blue Nile district, Sudan
48. Notes on the traditional use of plants to treat snake bite in northern Papua New Guinea
49. Contribution to the knowledge of Rifian traditional medicine. II: Folk medicine in Ksar Lakbir District
50. An ethnopharmacological study from the Coimbatore district, Tamil Nadu, India: Traditional knowledge compared with modern biological science
51. An ethnopharmacological study from Thane District, Maharashtra, India: Traditional knowledge compared with modern biological science
52. An ethnopharmacological study from Kulu District, Himachal Pradesh, India: Traditional knowledge compared with modern biological science
53. Traditional healers and the treatment of sexually transmitted illnesses in rural Zambia
54. An ethnobotanical study of herbal drugs of Gourma district, Mali
55. Plants employed for hypotensive infusions in urban areas of Argentina
56. Ethnobotany of the Sumu (Ulwa) of south-eastern Nicaragua and the comparisons with Miskitu plant lore
57. Medicinal plants in Khao Kho district, Phetchabun Province, Thailand
58. Studies on pharmaceutical ethnobotany in the regions of L'Alt Emporda and Les Guilleries
59. Tropical rain forests: Potential source of new drugs?
60. NAPRALERT: Computer handling of natural product research data
61. Computer services for research on plants for fertility regulation
62. Sweetening agents of plant origin: Literature search for candidate sweet plants
63. Potential sweetening agents of plant origin. III: Organoleptic evaluation of Stevia leaf herbarium samples for sweetness
64. Ethnopharmacologic studies. I: Rapid solution to a problem-oral use of Heliopsis longipes-by means of a multidisciplinary approach
65. World Health Organization, the Special Programme of Research, Development and Research Training in Human Reproduction Task Force on Indigenous Plants for Fertility Regulation
66. Yuehchukene: A novel indole alkaloid with anti-implantation activity
67. From plant to patient: An ethnomedical approach to the identification of new drugs for the treatment of NIDDM
68. SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri(sangre de drago)
69. Management of protease inhibitor-associated diarrhea
70. Antihyperglycemic activities of cryptolepine analogues: An ethnobotanical lead structure isolated from Cryptolepis sanguinolenta
71. Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: Its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities
72. Cryptolepis sanguinolenta: An ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent
73. Maprouneacin, a new daphnane diterpenoid with potent antihyperglycemic activity from Maprounea africana
74. Triterpenoid compound for the treatment of diabetes
75. Hypoglycemic agents from Harungan or Vismia spp. WD 98 25,639
76. Novel terpenoid-type quinones isolated from Pycnanthus angolensis of potential utility in the treatment of type 2 diabetes
77. Masoprocol (nordihydroguaiaretic acid): A new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata)
78. Natural product drug discovery and development: New perspectives on international collaboration
79. Logistics and politics in plant development
80. Biological diversity, indigenous knowledge, drug discovery and intellectual property rights: Creating reciprocity and maintaining relationships
81. Rights to the benefits of research: Compensating indigenous peoples for their intellectual contribution
82. Biodiversity prospecting and benefit-sharing: Perspectives from the field